{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:10:08Z","timestamp":1780733408673,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004508","name":"Prince of Songkla University","doi-asserted-by":"publisher","award":["PHA5111990044S"],"award-info":[{"award-number":["PHA5111990044S"]}],"id":[{"id":"10.13039\/501100004508","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijbiomac.2025.144734","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T11:08:29Z","timestamp":1748344109000},"page":"144734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P3","title":["Synthesis and characterization of 5-aminosalicylic acid-azobenzyl-chitosan conjugates-based prodrugs for the colon targeted delivery in dextran sodium sulfate (DSS)-induced ulcerative colitis"],"prefix":"10.1016","volume":"318","author":[{"given":"Sirinporn","family":"Nalinbenjapun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasikarn","family":"Sripetthong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuanjit","family":"Chaimongkolnukul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warayuth","family":"Sajomsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitchamai","family":"Ovatlarnporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144734_bb0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"5","author":"Alatab","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144734_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ecco-jcc\/jjv218","article-title":"Self-reported symptom burden in individuals with inflammatory bowel disease","volume":"10","author":"Farrell","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144734_bb0015","article-title":"Ulcerative colitis (primer)","volume":"6","author":"Taku","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2036.2006.03069.x","article-title":"Mode of action and delivery of 5-aminosalicylic acid\u2013new evidence","volume":"24","author":"Desreumaux","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144734_bb0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2036.1993.tb00110.x","article-title":"The mode of action of the aminosalicylates in inflammatory bowel disease","volume":"7","author":"Greenfield","year":"1993","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.144734_bb0030","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1002\/jps.24103","article-title":"On the colonic bacterial metabolism of azo-bonded prodrugsof 5-aminosalicylic acid","volume":"103","author":"Sousa","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144734_bb0035","doi-asserted-by":"crossref","first-page":"G371","DOI":"10.1152\/ajpgi.00102.2009","article-title":"Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting","volume":"297","author":"Dahan","year":"2009","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0040","doi-asserted-by":"crossref","unstructured":"Feagan, B.G., MacDonald, J.K. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis, Cochrane Database Syst. Rev. (10) (2012).","DOI":"10.1002\/14651858.CD000544.pub3"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144734_bb0045","doi-asserted-by":"crossref","DOI":"10.4103\/0975-8453.59516","article-title":"Role of natural polymers in the development of multiparticulate Systems for Colon Drug Targeting","volume":"1","author":"Das","year":"2010","journal-title":"Systematic Reviews in pharmacy"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0050","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1208\/s12249-015-0350-9","article-title":"Colon-targeted oral drug delivery systems: design trends and approaches","volume":"16","author":"Amidon","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.144734_bb0055","first-page":"21","article-title":"Colon targeted drug delivery system-a novel perspective","volume":"2","author":"Kolte","year":"2012","journal-title":"Asian J. Biomed. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144734_bb0060","article-title":"Developments in colon specific drug delivery systems-a review","volume":"5","author":"Shah","year":"2014","journal-title":"Pharm. Sci. Monit."},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0065","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2165\/00003495-200565140-00006","article-title":"Advances in colonic drug delivery","volume":"65","author":"Basit","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0070","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1007\/s10570-018-1904-2","article-title":"Design and synthesis of functionalized cellulose nanocrystals-based drug conjugates for colon-targeted drug delivery","volume":"25","author":"Tang","year":"2018","journal-title":"Cellulose"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jconrel.2024.04.016","article-title":"The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome","volume":"369","author":"McCoubrey","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1023\/A:1011033121528","article-title":"Colonic drug delivery: prodrug approach","volume":"18","author":"Sinha","year":"2001","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144734_bb0085","first-page":"1251","article-title":"Mutual prodrugs for colon targeting: a review","volume":"4","author":"Hammoodi","year":"2022","journal-title":"Eurasian Chem. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144734_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.22159\/ijap.2024v16i2.49293","article-title":"A review on development of colon targeted drug delivery system","volume":"16","author":"Muhammed","year":"2024","journal-title":"Int. J. Appl. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0095","doi-asserted-by":"crossref","first-page":"1452300","DOI":"10.3389\/fphar.2024.1452300","article-title":"Safety assessment of sulfasalazine: a pharmacovigilance study based on FAERS database","volume":"15","author":"Ye","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144734_bb0100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/gut.49.4.552","article-title":"Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study","volume":"49","author":"Mahmud","year":"2001","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144734_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00054725-199706000-00001","article-title":"Alternatives to sulfasalazine: a meta-analysis of 5-ASA in the treatment of ulcerative colitis","volume":"3","author":"Sutherland","year":"1997","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144734_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10717540490280778","article-title":"Polysaccharides for colon targeted drug delivery","volume":"11","author":"Chourasia","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118530","article-title":"Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: a review","volume":"272","author":"Cui","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.144734_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5173(01)00720-7","article-title":"Polysaccharides in colon-specific drug delivery","volume":"224","author":"Sinha","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0125","doi-asserted-by":"crossref","unstructured":"Hirano, S., Seino, H., Akiyama, Y., Nonaka, I. Chitosan: a biocompatible material for oral and intravenous administrations. Progress in Biomedical Polymers. Springer1990. pp. 283\u2013290.","DOI":"10.1007\/978-1-4899-0768-4_28"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.144734_bb0130","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/S0142-9612(02)00011-X","article-title":"In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents","volume":"23","author":"Zhang","year":"2002","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.144734_bb0135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.polymdegradstab.2006.04.028","article-title":"Influence of molecular parameters on the degradation of chitosan by a commercial enzyme","volume":"92","author":"Li","year":"2007","journal-title":"Polym. Degrad. Stab."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144734_bb0140","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1002\/jps.21271","article-title":"An investigation into the digestion of chitosan (noncrosslinked and crosslinked) by human colonic bacteria","volume":"97","author":"McConnell","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144734_bb0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/ijms21020499","article-title":"Antimicrobial chitosan conjugates: current synthetic strategies and potential applications","volume":"21","author":"Qin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.101397","article-title":"Chitosan-5-aminosalicylic acid conjugates for colon-specific drug delivery: methods of preparation and in vitro evaluations","volume":"57","author":"Nalinbenjapun","year":"2020","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144734_bb0155","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/bc050357y","article-title":"Chitosan\u2212 pentaglycine\u2212 phenylboronic acid conjugate: a potential colon-specific platform for calcitonin","volume":"17","author":"Smoum","year":"2006","journal-title":"Bioconjug. Chem."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.144734_bb0160","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.3390\/polym13234118","article-title":"Chitosan functionalization: covalent and non-covalent interactions and their characterization","volume":"13","author":"Nicolle","year":"2021","journal-title":"Polymers"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144734_bb0165","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2174\/1389200218666171031150001","article-title":"Conjugation strategies for colonic delivery and its application in colorectal cancer therapy","volume":"18","author":"Tran","year":"2017","journal-title":"Curr. Drug Metab."},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.144734_bb0170","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.2174\/156802611797183249","article-title":"Rational design and development of colon-specific prodrugs","volume":"11","author":"Dhaneshwar","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144734_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijbiomac.2008.03.010","article-title":"Synthesis and characterization of N-aryl chitosan derivatives","volume":"43","author":"Sajomsang","year":"2008","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144734_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.aca.2004.06.033","article-title":"Chelating resin from functionalization of chitosan with complexing agent 8-hydroxyquinoline: application for metal ions on line preconcentration system","volume":"521","author":"Martins","year":"2004","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144734_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(02)00461-3","article-title":"Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid","volume":"88","author":"Wiwattanapatapee","year":"2003","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.144734_bb0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2008.09.058","article-title":"Poly (ethylene glycol)-mesalazine conjugate for colon specific delivery","volume":"368","author":"Canevari","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.144734_bb0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejpb.2014.05.011","article-title":"Carboxymethylcellulose\u2013tetrahydrocurcumin conjugates for colon-specific delivery of a novel anti-cancer agent, 4-amino tetrahydrocurcumin","volume":"88","author":"Plyduang","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144734_bb0200","first-page":"145","article-title":"N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats","volume":"416","author":"Mura","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144734_bb0205","first-page":"4557","article-title":"A guide to histomorphological evaluation of intestinal inflammation in mouse models","volume":"7","author":"Erben","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0210","doi-asserted-by":"crossref","unstructured":"Pretsch, E., B\u00fchlmann, P., Affolter, C., Pretsch, E., Bhuhlmann, P., Affolter, C. Structure determination of organic compounds. Springer2000.","DOI":"10.1007\/978-3-662-04201-4"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10973-009-0668-1","article-title":"Thermal behavior of drugs: investigation on decomposition kinetic of naproxen and celecoxib","volume":"102","author":"Sovizi","year":"2010","journal-title":"J. Therm. Anal. Calorim."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.144734_bb0220","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3390\/molecules15042257","article-title":"Controlled release of 5-Aminosalicylic acid (5-asa) from new biodegradable polyurethanes","volume":"15","author":"Kenawy","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00289-008-0012-0","article-title":"Preparation and in vitro controlled release behavior of a novel pH-sensitive drug carrier for colon delivery","volume":"62","author":"Xu","year":"2009","journal-title":"Polym. Bull."},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0230","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jconrel.2020.09.026","article-title":"Recent advances in colon drug delivery systems","volume":"327","author":"Ar\u00e9valo-P\u00e9rez","year":"2020","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.144734_bb0235","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.3390\/pharmaceutics14122762","article-title":"Time-based formulation strategies for colon drug delivery","volume":"14","author":"Gazzaniga","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.144734_bb0240","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1021\/ie801295y","article-title":"A novel, potential microflora-activated carrier for a colon-specific drug delivery system and its characteristics","volume":"48","author":"Wang","year":"2009","journal-title":"Ind. Eng. Chem. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144734_bb0245","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/jbm.a.34988","article-title":"Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers","volume":"102","author":"Ma","year":"2014","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2024.100162","article-title":"Potential and prospects of reductases in azo dye degradation: a minireview","volume":"4","author":"Aragaw","year":"2024","journal-title":"Microbe"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144734_bb0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1573413711666150624170518","article-title":"Enzyme-responsive nanoparticles for anticancer drug delivery","volume":"12","author":"Kuang","year":"2016","journal-title":"Curr. Nanosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.144734_bb0260","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1021\/acs.jmedchem.1c02166","article-title":"Discovery of a Colon-targeted azo prodrug of Tofacitinib through the establishment of Colon-specific delivery systems constructed by 5-ASA\u2013PABA\u2013MAC and 5-ASA\u2013PABA\u2013diamine for the treatment of ulcerative colitis","volume":"65","author":"Zhao","year":"2022","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.144734_bb0265","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12951-024-02724-w","article-title":"Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy","volume":"22","author":"Tang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0270","first-page":"28","article-title":"Enzyme specific drug delivery system: a potential approach for colon targeting","author":"Soni","year":"2015","journal-title":"Current Research in Pharmaceutical Sciences"},{"key":"10.1016\/j.ijbiomac.2025.144734_bb0275","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1023\/A:1015849700421","article-title":"Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects","volume":"8","author":"Coupe","year":"1991","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.144734_bb0280","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1021\/acs.jafc.0c06755","article-title":"Troxerutin improves dextran sulfate sodium-induced ulcerative colitis in mice","volume":"69","author":"Wang","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144734_bb0285","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/biomedicines12081764","article-title":"Establishment and evaluation of a mouse model of experimental ulcerative colitis induced by the gavage Administration of Dextran Sulfate Sodium","volume":"12","author":"Wang","year":"2024","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.144734_bb0290","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s00018-022-04471-3","article-title":"5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism","volume":"79","author":"Huang","year":"2022","journal-title":"Cell. Mol. Life Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025052869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025052869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:20:11Z","timestamp":1762240811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025052869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":58,"alternative-id":["S0141813025052869"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144734","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and characterization of 5-aminosalicylic acid-azobenzyl-chitosan conjugates-based prodrugs for the colon targeted delivery in dextran sodium sulfate (DSS)-induced ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"144734"}}